David P Southwell's Net Worth
$23.2 Million
Who is David P Southwell?
David P Southwell has an estimated net worth of $23.2 Million. This is based on reported shares across multiple companies, which include Spero Therapeutics, Inc., ROCKET PHARMACEUTICALS, INC., PTC THERAPEUTICS, INC., TScan Therapeutics, Inc., THL Credit, Inc., HUMAN GENOME SCIENCES INC, SEPRACOR INC /DE/, and BIOSPHERE MEDICAL INC.
SEC CIK
David P Southwell's CIK is 0001251553
Past Insider Trading and Trends
2010 was David P Southwell's most active year for acquiring shares with 23 total transactions. David P Southwell's most active month to acquire stocks was the month of April. 2007 was David P Southwell's most active year for disposing of shares, totalling 150 transactions. David P Southwell's most active month to dispose stocks was the month of August. 2007 saw David P Southwell paying a total of $12,743,100.00 for 547,500 shares, this is the most they've acquired in one year. In 2007 David P Southwell cashed out on 602,276 shares for a total of $11,332,699.72, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Spero Therapeutics, Inc. (SPRO) Snapshot price: $1.45
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ROCKET PHARMACEUTICALS, INC. (RCKT) Snapshot price: $28.77
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +20.62% | 19.62K |
$14.33 | -$1,513,217.28 | 114.78K |
Apr 12 - Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
| -28.95% | -38.77K |
$15.19 | -$588,885.92 | 95.16K |
Dec 13
| |||
Form 4
| +247.55% | 95.39K |
$15.13 | -$873,458.28 | 133.93K |
Nov 28 - Dec 7
| |||
Form 4
| +131.30% | 21.88K |
—
|
—
| 38.53K |
Mar 29 - Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
| +2,169.98% | 60K |
$1.75 | $105,000.00 | 62.77K |
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PTC THERAPEUTICS, INC. (PTCT) Snapshot price: $26.79
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +38.10% | 4K |
—
|
—
| 14.5K |
Feb 15
| |||
Form 4
|
—
|
0
|
$34.52 | -$377,350.85 | 10.5K |
Apr 17
| |||
Form 4
|
—
|
0
|
$34.03 | -$82,368.67 | 10.5K |
Mar 31
| |||
Form 4
|
—
|
0
|
$36.08 | -$180,455.98 | 10.5K |
Mar 27
| |||
Form 4
| +61.54% | 4K |
—
|
—
| 10.5K |
Jan 5
| |||
Form 4
| +96.97% | 3.2K |
—
|
—
| 6.5K |
Jan 7
| |||
Form 4
| +100.00% | 1.65K |
—
|
—
| 3.3K |
Jan 6
| |||
Form 4
|
—
|
0
|
$31.28 | -$1,094,034.00 | 1.65K |
Scheduled
|
Oct 16
| ||
Form 4
|
∞
| 1.65K |
—
|
—
| 1.65K |
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| -100.00% | -8.60K |
$29.19 | -$958,944.00 |
0
|
Scheduled
|
Jul 6
| ||
Form 4
| -21.22% | -2.32K |
$69.04 | -$159,957.47 | 8.6K |
Scheduled
|
Mar 23
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| -17.50% | -2.32K |
$30.93 | -$71,665.95 | 10.92K |
Scheduled
|
Mar 21
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TScan Therapeutics, Inc. (TCRX) Snapshot price: $5.85
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 25
| |||
Form 4
| +17.06% | 25K |
$3.59 | $89,821.00 | 171.57K |
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
| +49.71% | 48.67K |
$1.97 | $95,879.90 | 146.57K |
Dec 23
| |||
Form 4
| +12.66% | 11K |
$8.73 | $96,066.30 | 97.9K |
Sep 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
THL Credit, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +45.83% | 12.1K |
$13.00 | $157,277.00 | 38.5K |
Dec 6
| |||
Form 4
| +0.76% | 200 |
$12.84 | $2,568.00 | 26.4K |
Nov 24
| |||
Form 4/A
| +0.77% | 201 |
$12.83 | $2,579.34 | 26.2K |
Nov 22 - Nov 23
| |||
Form 4
| -0.77% | -201.00 |
$12.83 | -$2,579.34 | 26.2K |
Nov 22 - Nov 23
| |||
Form 4
| +84.39% | 11.9K |
$12.84 | $152,770.99 | 26K |
Nov 18 - Nov 19
| |||
Form 4
|
∞
| 14.1K |
$12.84 | $181,030.86 | 14.1K |
Nov 16 - Nov 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||